You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 25 No. 2, August 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (39)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Type III Glycogenosis

An Adult With Diffuse Weakness and Muscle Wasting

James A. Brunberg, MD; William F. McCormick, MD; Sydney S. Schochet, Jr., MD

Arch Neurol. 1971;25(2):171-178.


Abstract

A 43-year-old man with an eight-month history of muscular weakness and wasting was found to have an abnormal electromyographic study with muscle biopsy demonstrating glycogen storage. Laboratory studies revealed a diabetic glucose tolerance curve and elevated serum glutamic oxaloacetic transaminase, creatine phosphokinase, lactic dehydrogenase activities. Galactose and glycerol tolerance was normal, while epinephrine and glucagon failed to elevate blood glucose. No elevation of blood lactic acid followed ischemic exercise. Muscle enzyme assay demonstrated the absence of amylo-1, 6-glucosidase activity, and electron microscopic studies revealed subsarcolemmal and intrasarcoplasmic accumulations of glycogen. The clinical, electromyographic, laboratory, and morphologic findings in our patient are compared with previous reports of type III glycogenosis and with other glycogenoses characterized by muscle storage. Among patients with type III glycogenosis three have been mentioned, but not fully reported, with similar weakness and wasting.



Author Affiliations

Iowa City

From the departments of neurology (Drs. Brunberg and McCormick) and pathology, Division of Neuropathology (Drs. McCormick and Schochet), and the Neurosensory Center, University of Iowa Hospitals, Iowa City.


Footnotes

Accepted for publication Jan 29, 1971.

Reprint requests to Department of Neurology, University Hospitals, Iowa City 52240 (Dr. Brunberg).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Different clinical aspects of debrancher deficiency myopathy
Kiechl et al.
J. Neurol. Neurosurg. Psychiatry 1999;67:364-368.
ABSTRACT | FULL TEXT  

Glycogen Storage Disease Type III (Glycogen Debranching Enzyme Deficiency): Correlation of Biochemical Defects with Myopathy and Cardiomyopathy
Coleman et al.
ANN INTERN MED 1992;116:896-900.
ABSTRACT  

Clinical Varieties of Neuromuscular Disease in Debrancher Deficiency
Cornelio et al.
Arch Neurol 1984;41:1027-1032.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.